177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.

Clinical trial NCT02088645 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02088645
Sponsor: University Hospital, Basel, Switzerland
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Thyroid Cancer, Medullary Neuroendocrine Tumor of the Lung Grade 1 and 2 Neuroendocrine Tumor of the Thymus Grade 1 and 2 Neuroendocrine Tumor GEP Grade 1-3

Start date: 2015-04-01
Primary completion: 2027-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.